Algeta Recruits Bayer To Deliver Prostate Cancer Drug Alpharadin To Market
This article was originally published in The Pink Sheet Daily
Executive Summary
Big Pharma still hot for castration-resistant prostate cancer drugs, despite Phase III burns in the past.